Objective: The purpose of this prospective nonrandomized study was to evaluate cone beam computed tomography (CBCT) for technical assessment of standard and complex endovascular aortic repair.
Objective: The purpose of this prospective nonrandomized study was to evaluate cone beam computed tomography (CBCT) for technical assessment of standard and complex endovascular aortic repair.
Methods: There were 155 patients (121 male; mean age, 74 6 8 years) enrolled in a prospective study between 2016 and 2017. A total of 170 aortic procedures were investigated, including 85 fenestrated-branched endovascular aneurysm repairs (F-BEVARs), 42 abdominal and thoracic EVARs, 32 iliac branch devices, and 11 aorta-related interventions. Technical assessment was done using CBCT with and without contrast enhancement, digital subtraction angiography (DSA), and computed tomography angiography (CTA). Patients with stage 3B or stage 4 chronic kidney disease had CBCT without contrast enhancement. Radiation exposure (mean dose-area product), effective dose (ED), and contrast material volume were analyzed. End points were presence of any endoleak, positive findings warranting possible intervention (stent kink/ compression, type I/III endoleak, dissection, thrombus), and need for secondary intervention.
Results: Radiation exposure and contrast material volume were significantly higher (P < .05) for F-BEVAR compared with other aortic procedures (172 6 100 Gy$cm 2 vs 122 6 92 Gy$cm 2 and 143 6 59 mL vs 123 6 49 mL). ED averaged 51 6 24 mSv for the aortic procedure and DSA, 17 6 14 mSv for CBCT, and 34 6 17 mSv for CTA imaging. Endoleak detection was significantly higher (P < .001) with CBCT (62%) compared with DSA (19%) and CTA (45%). CBCT identified 49 positive findings in 43 patients (29%), higher for F-BEVAR compared with other aortic procedures (35% vs 16%; P ¼ .01). Positive findings included stent compression/kink in 26 patients (17% ; Fig 1) , type I/III endoleak in 16 patients (10%), and arterial dissection/thrombus in 7 patients (5%). Of these, 28 patients (18%) had positive findings that prompted an intraoperative (17%) or delayed intervention (1%). Another 15 patients (10%) with minor positive findings were observed with no clinical consequence. DSA alone would not have detected positive findings in 34 of 43 patients (79%), including 21 patients (62%) who needed secondary interventions. CTA diagnosed three (2%) additional endoleaks requiring intervention (one type IB, two type III) that were not diagnosed by CBCT. Replacing DSA and CTA by CBCT would have resulted in 53% 6 13% reduction in contrast material volume and 56% 6 12% reduction in ED (Fig 2; P < .05).
Conclusions: CBCT reliably detected positive findings, prompting immediate revisions in nearly one of five patients, with the highest rates among F-BEVAR patients. Detection of any endoleak was higher with CBCT compared with DSA or CTA, but most endoleaks were observed. DSA alone failed to detect positive findings warranting secondary interventions. 
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Objective: Whereas open repair is the "gold standard" for most aortic arch diseases, a subgroup of patients would profit from an endovascular approach. The introduction of branched stent grafts with dedicated design to address the challenges of the ascending aorta and the aortic arch has opened an entire new area of treatment for these patients. We investigate the early outcomes of branched thoracic endovascular repair (b-TEVAR) in various types of diseases of the aortic arch.
Methods: Retrospective analysis was conducted of prospectively collected data from a single center of all consecutive patients treated with b-TEVAR. The indication for endovascular repair was consented in an interdisciplinary case conference. All patients were treated with a custom-made arch branched device with two internal branches (Cook Medical, Bloomington, Ind) and cervical debranching. Study end points were technical success, 30-day mortality, and complications as well as late outcomes. 
